Back to News
Market Impact: 0.2
Ginkgo Bioworks Holdings Consensus Price Target Raised 14.29% to $8.16
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year price target for Ginkgo Bioworks Holdings was revised to $8.16 per share as of October 20, 2026, up 14.29% from $7.14 on September 29, 2026. The figures reflect an aggregate analyst target; the article provides no share-price reaction or further analyst rationale.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
DNA0.20
More News
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Jefferies raises Zymeworks stock price target on Roche deal
- Truist raises United Rentals stock price target on strong margins
- GM stock analysis: cheap valuation meets falling estimates after earnings drop
- Restaurant earnings will test whether owning more brands pays off
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: New Reporting Features and More Sources for Document Search
- How to Evaluate AI Report Writers for Financial Analysis